NCCN Guidelines for Patients® | Multiple Myeloma - page 72

72
NCCN Guidelines for Patients™: Multiple Myeloma
Version 1.2012
Part 8: Dictionary
Contrast material
A dye put into your body to make
clearer pictures during imaging tests.
Control group
Patients in research who don’t receive
a new treatment.
Core-needle biopsy
Removal of a large tissue sample
with a thick, hollow needle to test for
disease.
Creatinine
A waste product of muscles that is
filtered out of blood into urine by the
kidneys.
Cryopreservation
The process of cooling and storing
cells, tissues, or organs at very cold
temperatures.
Curative treatment
Treatment used to fully rid the body of
a disease.
Diagnosis
To identify a disease.
Deoxyribonucleic acid (DNA)
A chain of chemicals inside cells that
contains coded instructions for making
and controlling cells.
Donor
A person who gives blood, cells,
tissue, or an organ to another person.
Donor lymphocyte infusion
A cancer treatment that transfers
white blood cells from a person, who
already gave blood-forming cells, to
the same patient.
Electrolytes
Minerals in blood that carry an electric
charge and control some body
functions.
Engraftment
When transplanted stem cells begin
to make blood cells in a patient’s bone
marrow.
Erythropoeitin
A drug used to treat patients with low
red blood cell counts.
External beam radiation therapy
(EBRT)
Radiation therapy received from a
machine outside the body.
Extraosseous
Occurring outside the bone.
Fat pad
The fat that is just under the skin of
the abdomen.
Fatigue
Severe tiredness despite getting
enough sleep.
Food and Drug Administration
(FDA)
A federal government agency that
regulates drugs and food.
Fine-needle aspiration
Removal of a small tissue sample with
a very thin needle to test for disease.
Free light chain
Fragments of M-proteins that are
made by myeloma cells.
1...,62,63,64,65,66,67,68,69,70,71 73,74,75,76,77,78,79,80,81,82,...84
Powered by FlippingBook